CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (USD $)	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Operating Activities
Net Income	$ 686,121	$ 1,775,418
Bad debt expenses	13,338	64,089
Depreciation expense	116,545	51,134
Amortization expense	16,269	15,901
Stock based compensation	62,071	71,985
Loss on disposal of fixed asset	5,651	13,383
Changes in operating assets and liabilities:
(Increase)/Decrease in commission receivable	101,059	(402,432)
(Increase)/Decrease in enrolment fee receivable	(1,572)	(2,988)
(Increase)/Decrease in deposit and prepayment	66,437	(11,932)
(Increase)/Decrease in fiduciary asset	(2,008,731)	(1,852,344)
(Increase)/Decrease in other receivable	26,853	356,869
Increase/(Decrease) in accounts payable	2,159,253	1,228,890
Increase/(Decrease) in claims payable	20,229	37,441
Increase/(Decrease) in other payable	(569,373)	403,290
Increase/(Decrease) in accrued expenses	(33,952)	(99,996)
Increase/(Decrease) in deferred revenue	3,500	3,500
Increase/(Decrease) in income tax payable	175,430	381,924
Net cash provided by operating activities	839,128	2,034,132
Investing Activities
Loan made to third parties		(3,000,000)
Cash paid for purchase of fixed assets	(169,608)	(23,328)
Sales proceeds for disposal of fixed assets		15,337
Net cash used in investing activities	(169,608)	(3,007,951)
Financing Activities
Dividend paid to non-controlling shareholders	(125,641)	(128,718)
Borrowings on related party debt	9,963	74,587
Principal payments on related party debt	(49,707)	(66,936)
Net cash (used) in financing activities	(165,385)	(121,067)
Net increase (decrease) in cash and cash equivalent	504,135	(1,094,886)
Effect of exchange rate changes on cash and cash equivalent	1,949	19,551
Initial cash and cash equivalent	8,203,957	8,051,872
Final cash and cash equivalent	8,710,041	6,976,537
Supplemental Disclosures of Cash Flow Information:
Interest paid		(2,836)
Income taxes paid	3,049	14,454
Non-Cash Transactions
Dividend received	11,226	9,745
Purchase price allocation adjustment		40,729
Change in fair value for Available-for-sales securities	$ 63,285	$ 82,661